Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other
companies in this sector in AUSTRALIA :
sales of 23.40 million Australian Dollars [US$15.43 million]
of which 100%
was Mesenchymal Precursor Cell),
(30.58 million Australian Dollars [US$20.17 million]
of which 98%
was Clinical Trials), and
Benitec Biopharma Inc
(16.60 million Australian Dollars [US$10.95 million]
During the year ended June of 2019, sales at
Clinuvel Pharmaceuticals Limited were A$31.61 million (US$20.85 million).
increase of 22.8%
versus 2018, when the company's sales were A$25.75 million.
This was the fifth consecutive year of sales increases at Clinuvel Pharmaceuticals Limited
(and since 2014, sales have increased a total of 957%).